Skip to content

People with HIV more likely to adhere to their antiretroviral therapy than treatment for other chronic health problems

Less frequent clinic visits for HIV care: fine tuning needed

MSF Community Adherence Club KwaZulu-Natal. Photo by Greg Lomas / Scholars and Gentlemen / Médecins sans Frontières

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

Joseph Eron at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

HIV drug resistance testing not a priority for resource-limited settings, trial finds

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

Nurse-led intervention improves adherence to ART and is cost-effective

Early adherence to ART key to long-term virological outcomes

Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000

Women significantly more likely than men to have suboptimal adherence to HIV therapy